600056.SS · 中国医药
China A-shares · RS rating 59 · As of 2026-10-14
| Price | 9.14 CNY |
|---|---|
| 1-day change | +0.8% |
| RS rating (overall / 1M / 3M / 12M) | 59 / 80 / 55 / 39 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 28 / 36 |
| Industry group (rank) | Medical-Hospitals (29) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.0% |
| Distance from 52-week high | +24.0% |
| Market cap (USD) | $2.0B |